NASDAQ: BRNSBarinthus Biotherapeutics PLC Stock Ownership - Who owns Barinthus Biotherapeutics?
Insider buying vs selling
Have Barinthus Biotherapeutics PLC insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when BRNS insiders and whales buy or sell their stock.
BRNS Shareholders
What type of owners hold Barinthus Biotherapeutics PLC stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Oxford Sciences Innovation PLC | 21.61% | 8,797,770 | $11.09M | Insider |
| Mg Investment Management Ltd | 15.13% | 6,160,946 | $7.76M | Insider |
| Mg PLC | 12.76% | 5,197,349 | $6.55M | Institution |
| Mg Alternatives Investment Management Ltd | 10.09% | 4,108,752 | $5.18M | Insider |
| William Enright | 4.36% | 1,773,300 | $2.23M | Insider |
| Alphabet Inc | 3.72% | 1,513,644 | $1.91M | Institution |
| Geoffrey Lynn | 1.57% | 640,639 | $807.21k | Insider |
| Baird Financial Group Inc | 0.47% | 192,461 | $242.50k | Institution |
| Thomas George Evans | 0.31% | 127,926 | $161.19k | Insider |
| Graham Griffiths | 0.26% | 104,209 | $131.30k | Insider |
BRNS vs Biotech Stocks
Barinthus Biotherapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.